260 related articles for article (PubMed ID: 8360594)
21. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
Walker TM; Burger CJ; Elgert KD
Cell Immunol; 1994 Apr; 154(1):342-57. PubMed ID: 8131207
[TBL] [Abstract][Full Text] [Related]
22. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
23. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide.
Yurochko AD; Askew D; Burger CJ; Elgert KD
Immunol Invest; 1990 Feb; 19(1):41-55. PubMed ID: 1692569
[TBL] [Abstract][Full Text] [Related]
24. Normal and tumor-bearing host macrophage factor-mediated modulation of mixed-lymphocyte reaction responsiveness: separation of T-lymphocyte subset susceptibility to enhancing and inhibitory factors.
Malick AP; Garner RE; Black SP; Elgert KD
Cell Immunol; 1984 May; 85(2):549-55. PubMed ID: 6232006
[TBL] [Abstract][Full Text] [Related]
25. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics.
Askew D; Yurochko AD; Burger CJ; Elgert KD
Immunol Lett; 1990; 24(1):21-9. PubMed ID: 1695610
[TBL] [Abstract][Full Text] [Related]
26. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.
Mullins DW; Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1997 Aug; 37(1):63-73. PubMed ID: 9285245
[TBL] [Abstract][Full Text] [Related]
27. Macrophages stimulated by receptor-ligand interactions exhibit differences in cell-cycle kinetics during tumor growth: stimulation at Mac-1 and Mac-3 receptors alters DNA synthesis.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunol Lett; 1992 Feb; 31(3):217-25. PubMed ID: 1548036
[TBL] [Abstract][Full Text] [Related]
28. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
J Leukoc Biol; 1992 Dec; 52(6):661-9. PubMed ID: 1464737
[TBL] [Abstract][Full Text] [Related]
29. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E.
Beharka AA; Wu D; Han SN; Meydani SN
Mech Ageing Dev; 1997 Feb; 93(1-3):59-77. PubMed ID: 9089571
[TBL] [Abstract][Full Text] [Related]
30. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth.
Garner RE; Malick AP; Elgert KD
J Leukoc Biol; 1986 Nov; 40(5):561-74. PubMed ID: 3464674
[TBL] [Abstract][Full Text] [Related]
31. Tumor growth and adherence change the expression of macrophage Mac-2.
Askew D; Burger CJ; Elgert KD
Cancer Lett; 1993 Apr; 69(1):67-74. PubMed ID: 8481895
[TBL] [Abstract][Full Text] [Related]
32. Temporal regulation by adrenergic receptor stimulation of macrophage (M phi)-derived tumor necrosis factor (TNF) production post-LPS challenge.
Ignatowski TA; Gallant S; Spengler RN
J Neuroimmunol; 1996 Apr; 65(2):107-17. PubMed ID: 8964892
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.
Boraschi D; Censini S; Tagliabue A
J Immunol; 1984 Aug; 133(2):764-8. PubMed ID: 6330202
[TBL] [Abstract][Full Text] [Related]
34. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity.
Ignatowski TA; Spengler RN
J Neuroimmunol; 1995 Aug; 61(1):61-70. PubMed ID: 7560013
[TBL] [Abstract][Full Text] [Related]
35. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
Mullins DW; Walker TM; Burger CJ; Elgert KD
Cancer Immunol Immunother; 1997 Oct; 45(1):20-8. PubMed ID: 9353423
[TBL] [Abstract][Full Text] [Related]
36. HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes.
Nokta MA; Hassan MI; Loesch KA; Pollard RB
Virology; 1995 Apr; 208(2):590-600. PubMed ID: 7747431
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
Elgert KD; Connolly KM
Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
[TBL] [Abstract][Full Text] [Related]
38. Divergence in macrophage insulin-like growth factor-I (IGF-I) synthesis induced by TNF-alpha and prostaglandin E2.
Fournier T; Riches DW; Winston BW; Rose DM; Young SK; Noble PW; Lake FR; Henson PM
J Immunol; 1995 Aug; 155(4):2123-33. PubMed ID: 7636260
[TBL] [Abstract][Full Text] [Related]
39. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
Tomioka H; Maw WW; Sato K; Saito H
Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
[TBL] [Abstract][Full Text] [Related]
40. Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2.
Ferreri NR; Sarr T; Askenase PW; Ruddle NH
J Biol Chem; 1992 May; 267(13):9443-9. PubMed ID: 1533632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
